Quotables
"Inventing is a combination of brains and materials. The more brains you use, the less material you need."
Charles Kettering
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| D636882 | Covering material | 04/26/2011 |
| D634850 | Covering material | 03/22/2011 |
| 7690494 | Conveyor device having a filling device for vertical flow of material, without demixing, of powdered media The invention relates to a conveyor device having a filling device (7) for vertical flow of material, without demixing, of powdered media having different particle sizes and particle densities, having the following features: a supply container (8) havi... | 04/06/2010 |
| D600353 | Covering material | 09/15/2009 |
| 7344733 | Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole The invention relates to an active-ingredient-containing, matrix-controlled transdermal therapeutic system for the use of pramipexole, ropinirole, pharmaceutically acceptable salts thereof or pharmaceutically acceptable derivatives thereof. ... | 03/18/2008 |
| 7220473 | Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system This present invention concerns a cover layer that is impermeable to the active substances and/or a removable protective layer of a transdermal therapeutic system, comprising a thermoplastic film which either directly contains the absorbing agents and channel-formin... | 05/22/2007 |
| 6967033 | Pharmaceutically active plant preparation for the treatment of migraine The invention relates to pharmaceutical combination preparations with synergistic action for the treatment of migraine. Said preparations contain plant-based components and/or preparations of Tanacetum parthenium in combination with Vitex agnus castus ... | 11/22/2005 |
| 6696413 | Pharmaceutical preparation with cyclosporin A The invention relates to a pharmaceutical preparation which consists of or contains cyclosporin A, an emulsifying -tocopherol derivative, an ethoxylation product of vegetable oils, fatty acids or fats as a further emulsifier and a pharmaceutically ... | 02/24/2004 |
| 6623752 | Patch for transdermal application for pergolid The invention relates to a patch for transdermal application of pergolid and its pharmaceutically acceptable salts.... | 09/23/2003 |
| 6579536 | Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient The invention relates to a solid, sustained-release pharmaceutical composition for oral administration containing tilidine mesylate as active ingredient.... | 06/17/2003 |
| 6537970 | Pharmaceutical composition The invention relates to a novel pharmaceutical combination comprising clindamycin and clotrimazole for use for vaginal infections.... | 03/25/2003 |
| 6440513 | Flat transdermal medicated self-adhesive patch The invention relates to a patch-shaped object, for example a TTS, patch, sticker or label, where the object comprises or is formed by an adhesive layer and a cover foil covering the adhesive layer having the same surface dimensions. The object further co... | 08/27/2002 |
| 6395297 | Transdermal preparation contacting a loratidine metabolite with antihistaminic activity A transdermal patch contains an active loratidine metabolite contained with polyacrylate polymer matrix. The transdermal patch provides pharmaceutically useful transdermal flux rates over time.... | 05/28/2002 |
| 6284269 | Pharmaceutical compositions of meloxicam with improved solubility and bioavailability Pharmaceutical compositions containing enolic carboxamide type antiinflammatory agent meloxicam that exhibit improved wettability, aqueous solubility, dissolution behaviour over a broad range of pH, and that are prepared by crystal structure modification ... | 09/04/2001 |
| 6248758 | Pharmaceutical antacid A pharmaceutical formulation comprising a benzimidazole derivative as active ingredient, and as excipients, at least one cyclodextrin and at least one amino acid.... | 06/19/2001 |
| 6204255 | Solid, non-deliquescent formulations of sodium valproate Non-deliquescent formulation comprising or consisting of sodium valproate and cyclodextrin having a molar ratio of sodium valproate to cyclodextrin within the range of from 1:0.01 to 1:0.09.... | 03/20/2001 |
| 6165498 | Transdermal preparation containing a loratidine metabolite with antihistaminic activity A transdermal patch contains an active loratidine metabolite contained with a polyacrylate polymer matrix. The transdermal patch provides pharmaceutically useful transdermal flux rates over time.... | 12/26/2000 |
| 6071964 | Diclofenac/gamma-cyclodextrin inclusion compounds The object of the present invention is an oral drug preparation containing the γ-cyclodextrin complex of diclofenac or pharmaceutically acceptable salts thereof, especially the sodium salt prepared by known methods, and by which the gastro-intestinal irr... | 06/06/2000 |
| 6022852 | Pharmaceutical composition containing cyclosporin A The invention relates to a pharmaceutical composition consisting of or containing cyclosporin A and -tocopherol or one of the derivatives thereof.... | 02/08/2000 |
| 5989585 | Transdermal therapeutic system (TTS) containing vitamin E for the treatment of drug dependency The invention relates to a transdermal therapeutic system (TTS) for the administration of active agents for substitution treatment of drug dependency or drug addiction.... | 11/23/1999 |
| 5910320 | Tablet or capsule having a content of stable ranitidine hydrochloride form 1 The invention relates to a tablet or capsule that is characterised by a powder mixture having a content of stable ranitidine hydrochloride Form 1 together with a carrier and/or diluent, and to manufacturing processes for the tablet.... | 06/08/1999 |
| 5904930 | Transdermal system in the form of a patch comprising a tamoxifen derivative A transdermal system in the form of a patch that comprises a tamoxifen derivative and an absorption-promoting additive for systemic administration.... | 05/18/1999 |
| 5874107 | Sustained release tablet containing diclofenac-Na and methylhydroxypropyl-cellulose as a sustained release agent The invention relates to a sustained release tablet containing diclofenac-Na as active material and methylhydroxypropylcellulose as sustained release agent.... | 02/23/1999 |
